skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Understanding the structural basis of HIV-1 restriction by the full length double-domain APOBEC3G

Journal Article · · Nature Communications

APOBEC3G, a member of the double-domain cytidine deaminase (CD) APOBEC, binds RNA to package into virions and restrict HIV-1 through deamination-dependent or deamination-independent inhibition. Mainly due to lack of a full-length double-domain APOBEC structure, it is unknown how CD1/CD2 domains connect and how dimerization/multimerization is linked to RNA binding and virion packaging for HIV-1 restriction. We report rhesus macaque A3G structures that show different inter-domain packing through a short linker and refolding of CD2. The A3G dimer structure has a hydrophobic dimer-interface matching with that of the previously reported CD1 structure. A3G dimerization generates a surface with intensified positive electrostatic potentials (PEP) for RNA binding and dimer stabilization. Unexpectedly, mutating the PEP surface and the hydrophobic interface of A3G does not abolish virion packaging and HIV-1 restriction. The data support a model in which only one RNA-binding mode is critical for virion packaging and restriction of HIV-1 by A3G.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); Canadian Institutes of Health Research (CIHR); USDOE Office of Science (SC)
Grant/Contract Number:
R01 AI150524; PJT162407
OSTI ID:
1763147
Journal Information:
Nature Communications, Vol. 11, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (63)

Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation journal May 2017
Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G journal November 2017
Structure-Guided Analysis of the Human APOBEC3-HIV Restrictome journal May 2014
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts journal December 2008
Computational Model and Dynamics of Monomeric Full-Length APOBEC3G journal October 2017
Complementary function of the two catalytic domains of APOBEC3G journal March 2005
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection journal December 2011
Crystal structures of APOBEC3G N-domain alone and its complex with DNA journal August 2016
Functional Analysis and Structural Modeling of Human APOBEC3G Reveal the Role of Evolutionarily Conserved Elements in the Inhibition of Human Immunodeficiency Virus Type 1 Infection and Alu Transposition journal September 2009
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution journal March 2018
Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA journal January 2018
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo journal May 2005
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface journal December 2015
Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All journal March 2014
APOBEC3G Oligomerization Is Associated with the Inhibition of Both Alu and LINE-1 Retrotransposition journal December 2013
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA journal April 2006
Retroviral restriction by APOBEC proteins journal November 2004
Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses journal June 2013
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex journal November 2003
A quantitative assay for HIV DNA integration in vivo journal May 2001
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity journal January 2005
From The Cover: A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor journal March 2004
The role of DNA shape in protein–DNA recognition journal October 2009
Nanoscale Characterization of Interaction of APOBEC3G with RNA journal March 2017
T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction journal December 2011
Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA journal July 2018
RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1 journal March 2009
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition journal October 2006
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities journal March 2005
1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure journal June 2016
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif journal August 2014
Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands journal August 2018
Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity journal November 2018
Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H journal February 2007
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications journal October 2008
Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis journal December 2009
Promiscuous RNA Binding Ensures Effective Encapsidation of APOBEC3 Proteins by HIV-1 journal January 2015
Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G journal March 2010
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA journal June 2018
From The Cover: A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) journal February 2004
APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA journal October 2017
The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements journal April 2008
Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect journal June 2006
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G journal October 2007
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts journal May 2003
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein journal July 2002
A Hydrodynamic Analysis of APOBEC3G Reveals a Monomer−Dimer−Tetramer Self-Association That Has Implications for Anti-HIV Function journal November 2009
The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism journal January 2018
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector journal April 1996
DNA Deamination Mediates Innate Immunity to Retroviral Infection journal February 2004
Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation journal June 2017
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution text January 2021
The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism dataset January 2017
DNA Deamination Mediates Innate Immunity to Retroviral Infection journal June 2003
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif journal July 2003
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G journal May 2015
A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action journal February 2004
Single-stranded DNA Scanning and Deamination by APOBEC3G Cytidine Deaminase at Single Molecule Resolution journal February 2012
Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs journal June 2004
APOBEC3G Subunits Self-associate via the C-terminal Deaminase Domain journal October 2008
Mutational Alteration of Human Immunodeficiency Virus Type 1 Vif Allows for Functional Interaction with Nonhuman Primate APOBEC3G journal June 2006
Association of Potent Human Antiviral Cytidine Deaminases with 7SL RNA and Viral RNP in HIV-1 Virions journal October 2010
Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation journal January 2007